journal cover

Role of image-guided biopsy and radiomics in the age of precision medicine

Chinese Clinical Oncology

Jan 24, 2020

Lambros TselikasThierry de Baere

Abstract

Modern oncology requires precise tumor assessment to drive effective therapies. Image-guided biopsies are the current standard of care to characterize molecular alterations safely and effectively, but have inherent limitations due to tumor heterogeneity and accessibility, as well as fro...read more

Mentioned in this Paper

Patient Care
Act Code - Oncology
Risk Assessment
Joints
Neoplasms
Computed Tomographic Colonography
Suspicion
Comprehension
Validation
Standardization
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Precision Medicine

Precision medicine is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the patient traits and specific molecular features of disease processes. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics

Related Papers

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer

Zhongguo fei ai za zhi = Chinese journal of lung cancerJune 24, 2017
Yuxin JiaoXiangpeng Zheng
Insights Into Imaging

Combining molecular and imaging metrics in cancer: radiogenomics

Insights Into ImagingJanuary 5, 2020
Roberto Lo GulloKatja Pinker
© 2020 Meta ULC. All rights reserved

Role of image-guided biopsy and radiomics in the age of precision medicine

Chinese Clinical Oncology

Jan 24, 2020

Lambros TselikasThierry de Baere

PMID: 31968981

DOI: 10.21037/cco.2019.12.02

Abstract

Modern oncology requires precise tumor assessment to drive effective therapies. Image-guided biopsies are the current standard of care to characterize molecular alterations safely and effectively, but have inherent limitations due to tumor heterogeneity and accessibility, as well as fro...read more

Mentioned in this Paper

Patient Care
Act Code - Oncology
Risk Assessment
Joints
Neoplasms
Computed Tomographic Colonography
Suspicion
Comprehension
Validation
Standardization

Similar Papers Found In These Feeds

Precision Medicine

Precision medicine is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the patient traits and specific molecular features of disease processes. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics

Related Papers

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer

Zhongguo fei ai za zhi = Chinese journal of lung cancerJune 24, 2017
Yuxin JiaoXiangpeng Zheng
Insights Into Imaging

Combining molecular and imaging metrics in cancer: radiogenomics

Insights Into ImagingJanuary 5, 2020
Roberto Lo GulloKatja Pinker
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/role-of-image-guided-biopsy-and-radiomics-in-the/31968981